CancerX shared on LinkedIn:
“Congratulations to CancerX member mPATH Health on a landmark year!
mPATH Health’s direct to patient digital navigation is helping more people complete the cancer screenings that save lives:
- Published in JAMA: lung cancer screening completion rose to 24.5% vs 17% with usual care, a 44% relative increase
- One of three JAMA papers presented at ERS Congress 2026 in Barcelona
- Only the second lung cancer screening program added to NCI’s Evidence-Based Cancer Control Programs
- Awarded DiMe’s Integrated Evidence Seal
- 100,000+ patients reached across lung, colorectal, and breast screening
Proud to be part of mPATH Health’s journey!
We share one goal: cutting cancer mortality by 50% by 2047. If you’re building toward it too, apply for the CancerX Accelerator 2027 cohort by signing in to your Constellation account..”
Other posts about CancerX on OncoDaily.